YP
GMAB icon

YANKCOM Partnership’s Genmab GMAB Stock Holding History

YANKCOM Partnership’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$2.68K – 338
2026
Q1 		$2.68K Hold
100
– – ﹤0.01% 323
2025
Q4 		$3.08K Buy
+100
New +$3.12K ﹤0.01% 332

Other funds holding GMAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

YANKCOM Partnership's GMAB Position: Q2 2026 in Review

YANKCOM Partnership sold out of Genmab (GMAB) in Q2 2026, closing a stake of 100 shares — an estimated $2.68K sold.

YANKCOM Partnership first reported a position in GMAB in Q4 2025 and held it in 2 quarters. The position peaked at $3.08K in Q4 2025. 117 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • YANKCOM Partnership reported no remaining Genmab position as of Q2 2026 after selling out during the quarter.
  • YANKCOM Partnership sold 100 Genmab shares in Q2 2026, an estimated $2.68K.
  • YANKCOM Partnership first reported a position in Genmab in Q4 2025 and held it in 2 quarters.
  • YANKCOM Partnership's Genmab position peaked at $3.08K in Q4 2025.
  • 117 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on YANKCOM Partnership's 13F filing for Q2 2026, filed 21 Jul 2026.